CANF logo

Can-Fite BioPharma (CANF) Cash From Financing

Annual CFF

$9.14 M
+$9.14 M+100.00%

December 31, 2023

Summary

Performance

1-Year Change

+100%

3-Year Change

-48.29%

5-Year Change

+108.43%

15-Year Change

+104.38%

CANF Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

56.69%
CANF annual cash flow from financing activities is higher than 56.69% of companies in Healthcare sector

High & Low

All-time High

$20.46 M
CANF annual cash flow from financing activities is currently -55.30% below its historical high of $20.46 million

3-Year Low

$0.00
CANF annual cash flow from financing activities is currently >+9900.00% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
CANF previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 10, 2025
CANF next annual earnings announcement is scheduled for Feb 10, 2025

OtherCANFcash flowmetrics:

Annual CFI

$498.00 K
CANF annual cash flow from investing activities is $498.00 thousand

Annual CFO

-$8.44 M
CANF annual cash flow from operations is -$8.44 million

Annual FCF

-$8.44 M
CANF annual free cash flow is -$8.44 million

Annual CAPEX

$2000.00
CANF annual capital expenditures is $2000.00

Quarterly CFF

N/A

June 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

CANF Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$6.57 M
CANF quarterly cash flow from financing activities is currently at an all-time high

3-Year Low

-
CANF quarterly cash flow from financing activities 3-year low is unknown

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
CANF previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

Feb 10, 2025
CANF next earnings announcement is scheduled for Feb 10, 2025

OtherCANFcash flowmetrics:

Quarterly CFI

-
CANF quarterly cash flow from investing activities value is unknown

Quarterly CFO

-
CANF quarterly cash flow from operations value is unknown

Quarterly FCF

-
CANF quarterly free cash flow value is unknown

Quarterly CAPEX

-
CANF quarterly capital expenditures value is unknown

TTM CFF

N/A

June 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

CANF TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$13.22 M
CANF TTM cash flow from financing activities is currently at an all-time high

3-Year Low

-
CANF TTM cash flow from financing activities 3-year low is unknown

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
CANF previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

Feb 10, 2025
CANF next earnings announcement is scheduled for Feb 10, 2025

OtherCANFcash flowmetrics:

TTM CFI

-
CANF TTM cash flow from investing activities value is unknown

TTM CFO

-
CANF TTM cash flow from operations value is unknown

TTM FCF

-
CANF TTM free cash flow value is unknown

TTM CAPEX

-
CANF TTM capital expenditures value is unknown

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

CANF Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+100.0%--
3 y3 years-48.3%--
5 y5 years+108.4%--

CANF Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-55.3%-100.0%
5 y5-year-55.3%-100.0%
alltimeall time-55.3%-100.0%

Can-Fite BioPharma Cash From Financing History

DateAnnualQuarterlyTTM
Dec 2023
$9.14 M(>+9900.0%)
-
-
Dec 2022
$0.00(-100.0%)
-
-
Dec 2021
$20.46 M(+15.7%)
-
-
Dec 2020
$17.68 M(+73.9%)
-
-
Dec 2019
$10.17 M(+131.8%)
-
-
Dec 2018
$4.39 M(-1.9%)
-
-
Dec 2017
$4.47 M(>+9900.0%)
-
-
Dec 2016
$0.00(-100.0%)
-
-
Dec 2015
$12.38 M(+7.9%)
-
-
Dec 2014
$11.47 M(-13.2%)
-
-
Dec 2013
$13.22 M
$5.97 M(+3658.3%)
$13.22 M(+80.5%)
Sep 2013
-
$158.90 K(-69.1%)
$7.32 M(+2.2%)
DateAnnualQuarterlyTTM
Jun 2013
-
$513.90 K(-92.2%)
$7.16 M(-10.9%)
Mar 2013
-
$6.57 M(+8399.9%)
$8.04 M(+436.2%)
Dec 2012
$1.50 M(-67.7%)
-
-
Dec 2012
-
$77.30 K(>+9900.0%)
$1.50 M(-75.0%)
Sep 2012
-
$300.00(-100.0%)
$5.99 M(-0.2%)
Jun 2012
-
$1.39 M(+4313.0%)
$6.00 M(+30.1%)
Mar 2012
-
$31.50 K(-99.3%)
$4.61 M(-0.7%)
Dec 2011
$4.64 M(+37.3%)
-
-
Dec 2011
-
$4.57 M(>+9900.0%)
$4.64 M(+5779.1%)
Sep 2011
-
$13.30 K(+786.7%)
$79.00 K(+20.2%)
Jun 2011
-
$1500.00(-97.7%)
$65.70 K(+2.3%)
Mar 2011
-
$64.20 K
$64.20 K
Dec 2010
$3.38 M
-
-

FAQ

  • What is Can-Fite BioPharma annual cash flow from financing activities?
  • What is the all time high annual CFF for Can-Fite BioPharma?
  • What is Can-Fite BioPharma annual CFF year-on-year change?
  • What is the all time high quarterly CFF for Can-Fite BioPharma?
  • What is the all time high TTM CFF for Can-Fite BioPharma?

What is Can-Fite BioPharma annual cash flow from financing activities?

The current annual CFF of CANF is $9.14 M

What is the all time high annual CFF for Can-Fite BioPharma?

Can-Fite BioPharma all-time high annual cash flow from financing activities is $20.46 M

What is Can-Fite BioPharma annual CFF year-on-year change?

Over the past year, CANF annual cash flow from financing activities has changed by +$9.14 M (+100.00%)

What is the all time high quarterly CFF for Can-Fite BioPharma?

Can-Fite BioPharma all-time high quarterly cash flow from financing activities is $6.57 M

What is the all time high TTM CFF for Can-Fite BioPharma?

Can-Fite BioPharma all-time high TTM cash flow from financing activities is $13.22 M